elranatamab will enhance the level or impact of ergotamine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Elranatamab will cause cytokine release syndrome (CRS) that could suppress activity of CYP enzymes, leading to increased publicity of CYP substrates.Simply because K2 spray on paper or Liquid K2 on Paper is produ